RANDOX NEFA (Non-Esterified Fatty Acids) FA115 Lot 485343, GTIN: 5055273203066.
FDA Device Recall #Z-0367-2020 — Class III — September 23, 2019
Recall Summary
| Recall Number | Z-0367-2020 |
| Classification | Class III — Low risk |
| Date Initiated | September 23, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Randox Laboratories, Limited |
| Location | Crumlin, N/A |
| Product Type | Devices |
| Quantity | 212 (19 US; 193 OUS) |
Product Description
RANDOX NEFA (Non-Esterified Fatty Acids) FA115 Lot 485343, GTIN: 5055273203066.
Reason for Recall
Non-Esterified Fatty Acids (NEFA) FA115 batch 485343 is not meeting the performance claims and should not be used in any further testing.
Distribution Pattern
WV (USA), International: GB, BE, CZ, FR, GR, IE, IT, NL, PL, SK, ES, CH, TR, AU, BR, MX, RU, SG, TW
Lot / Code Information
Catalogue number: FA115 GTIN: 05055273203066 Batch/Lot: 485343 Exp: Mar 2019
Other Recalls from Randox Laboratories, Limited
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1017-2025 | Class II | Randox Lipoprotein (a) - In vitro diagnostic (... | Dec 20, 2024 |
| Z-1018-2025 | Class II | Randox Lipoprotein (a) - In vitro diagnostic (I... | Dec 20, 2024 |
| Z-1349-2020 | Class II | RX Daytona Plus (with ISE/without ISE); Models ... | Dec 19, 2019 |
| Z-0412-2020 | Class II | Randox Liquid Cardiac Controls Catalogue Number... | Oct 4, 2019 |
| Z-0413-2020 | Class II | Randox Liquid Cardiac Controls Catalogue Number... | Oct 4, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.